Abstract
Rheumatoid arthritis (RA) is a systemic chronic autoinflammatory disease that eventually leads to a progressive destruction of cartilage and bone tissue of the joints. Early diagnosis of RA based on the clinical presentation and laboratory findings is of utmost importance to initiate adequate therapy. Therapeutic options have dramatically improved during the last 20 years due to the rise of biological and synthetic targeted therapies. Nevertheless, several unmet needs still exist that require further insights from basic research to uncover the cause(s) of RA.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Smolen JS, et al. Rheumatoid arthritis. Nat Rev Dis Primers. 2018;4:1–23.
Nell V, et al. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis. 2005;64:1731–6.
Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376:1094–108.
Aletaha D, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580–8.
Quinn M, Green M, Conaghan P, Emery P. How do you diagnose rheumatoid arthritis early? Best Pract Res Clin Rheumatol. 2001;15:49–66.
Young A, Koduri G. Extra-articular manifestations and complications of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2007;21:907–27.
Kvien TK, et al. Considerations for improving quality of care of patients with rheumatoid arthritis and associated comorbidities. RMD Open. 2020;6:e001211.
Colebatch AN, et al. EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis. 2013;72(6):804–14.
Smolen JS, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020;79(6):685–99.
Shea B, et al. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev. 2013;13(5):CD000951.
Doevendans E, Schellekens H. Immunogenicity of innovative and biosimilar monoclonal antibodies. Antibodies. 2019;8:21–10.
Mertens M, Singh JA. Anakinra for rheumatoid arthritis. Cochrane Database Syst Rev. 2009;41:CD005121.
Schwartz DM, et al. JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. Nat Rev Drug Discov. 2017;16:843–62.
Vlieland TPMV, Pattison D. Non-drug therapies in early rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2009;23:103–16.
Hagen K, Byfuglien M, Falzon L, Olsen S, Smedslund G. Dietary interventions for rheumatoid arthritis. Cochrane Database Syst Rev. 2009:CD006400.
Burmester G-R, et al. Evolving the comprehensive management of rheumatoid arthritis: identification of unmet needs and development of practical and educational tools. Clin Exp Rheumatol. 2020;38(6):1056–67.
Wong PKK, Hanrahan P. Management of vaccination in rheumatic disease. Best Pract Res Clin Rheumatol. 2019;32:720–34.
Smeele HTW, Dolhain RJEM. Current perspectives on fertility, pregnancy and childbirth in patients with Rheumatoid Arthritis. Semin Arthritis Rheu. 2019;49:S32–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Scheinecker, C., Aletaha, D. (2022). Rheumatoid Arthritis. In: Ali, Y. (eds) Rheumatology for Primary Care Providers. Springer, Cham. https://doi.org/10.1007/978-3-030-80699-6_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-80699-6_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-80698-9
Online ISBN: 978-3-030-80699-6
eBook Packages: MedicineMedicine (R0)